Clinical Significance of Molecular Alterations and Systemic Therapy for Meningiomas: Where Do We Stand?

Pellerino, Alessia; Bruno, Francesco; Palmiero, Rosa; Pronello, Edoardo; Bertero, Luca; Soffietti, Riccardo; Rudà, Roberta.

Pellerino A; Division of Neuro-Oncology, Department Neuroscience, University and City of Health and Science Hospital, 10126 Turin, Italy.
Bruno F; Division of Neuro-Oncology, Department Neuroscience, University and City of Health and Science Hospital, 10126 Turin, Italy.
Palmiero R; Division of Neuro-Oncology, Department Neuroscience, University and City of Health and Science Hospital, 10126 Turin, Italy.
Pronello E; Department of Neurology Unit, Department of Translational Medicine, University of Eastern Piedmont, 28100 Novara, Italy.
Bertero L; Pathology Unit, Department of Medical Sciences, University and City of Health and Science Hospital, 10126 Turin, Italy.
Soffietti R; Division of Neuro-Oncology, Department Neuroscience, University and City of Health and Science Hospital, 10126 Turin, Italy.
Rudà R; Division of Neuro-Oncology, Department Neuroscience, University and City of Health and Science Hospital, 10126 Turin, Italy.

Cancers (Basel) ; 14(9)2022 Apr 30.

Article en En | MEDLINE | ID: mdl-35565385